Medigus Ltd. ADR (MDGS)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Medigus Ltd. ADR stock is currently priced at $0.00, with a 24-hour trading volume of 0. It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.37 pivot point. If it approaches the $1.75 support level, significant changes may occur.

Medigus Ltd. ADR Stock (MDGS) Financials Data

Medigus Ltd. ADR (MDGS) Revenue 2024

MDGS reported a revenue (TTM) of $110.28 million for the quarter ending June 30, 2023, a +3,768% rise year-over-year.

Medigus Ltd. ADR (MDGS) Net Income 2024

MDGS net income (TTM) was -$14.43 million for the quarter ending June 30, 2023, a -280.02% decrease year-over-year.

Medigus Ltd. ADR (MDGS) Earnings per Share 2024

MDGS earnings per share (TTM) was -$8.70 for the quarter ending June 30, 2023, a -530.48% decline year-over-year.

Medigus Ltd. ADR Stock (MDGS) Latest News

Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business

GlobeNewswire Inc.

Medigus Reaps Success with First Installation of a Wireless Charging System for Automatic Car Parks

GlobeNewswire Inc.

Medigus: Revoltz Initiates on Exclusive Distribution Agreement of $2.7 Million in Revenues and Completes the Production of the First 50 PORTO Micro-Mobility EVs

GlobeNewswire Inc.

Medigus: Charging Robotics Announces Successful Installment of its Wireless Charging System for Automatic Car Parks

GlobeNewswire Inc.

Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation

GlobeNewswire Inc.

Medigus: Revoltz Opens for Pre-Orders of its Revolutionary Micro Mobility EV

GlobeNewswire Inc.

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.